Understanding viral dynamics is key to evaluating vaccine performance.

This peer-reviewed publication examines how mRNA-1273 vaccination influenced SARS-CoV-2 viral dynamics during the Phase 3 COVE trial. Learn how vaccination affected viral copy number, viral shedding, disease burden, and variant-specific efficacy, providing valuable insights into vaccine performance and clinical outcomes.

Key topics include:

• The effect of mRNA-1273 vaccination on SARS-CoV-2 viral copy number and shedding duration
• Reductions in COVID-19 disease burden and severity among vaccinated participants
• Vaccine efficacy against circulating variants, including Epsilon and Gamma lineages
• The role of viral dynamics data in understanding transmission risk and vaccine performance

As vaccines continue to play a critical role in infectious disease prevention, understanding viral kinetics and variant-specific responses remains essential. Learn how analyses from the COVE trial have contributed to our understanding of vaccine performance and informed future vaccine research.